December 2019 | SSG Compliance Recap

The U.S. Court of Appeals for the Fifth Circuit held that the Patient Protection and Affordable Care Act’s (ACA’s) individual mandate is unconstitutional. The Internal Revenue Service (IRS) released final instructions and final 1094-B, 1095-B, 1094-C, and 1095-C forms for 2019. The IRS also extended good-faith relief from penalties for employers that report inaccurate or incomplete information on the return or statement for 2019 ACA reporting.

President Trump signed the Further Consolidated Appropriations Act, 2020 that significantly affects provisions under the ACA, largely through one fee extension and the repeal of three taxes. The Centers for Medicare and Medicaid Services (CMS) updated its frequently asked questions (FAQs) on Section 111 Medicare Secondary Payer (MSP) prescription drug coverage reporting.

The Department of Health and Human Services (HHS) extended the comment period for the coverage transparency proposed rules. The Food and Drug Administration (FDA) released a proposed rule on the importation of certain drugs from Canada. The IRS updated its questions and answers on the individual shared responsibility provision to reflect the reduction in the individual shared responsibility penalty to $0 beginning in 2019.

Download the full recap to continue reading about:

• IRS Releases Final 2019 ACA Reporting Forms and Instructions
• Status of Court Case Challenging ACA Constitutionality
• President Signs Further Consolidated Appropriations Act, 2020
• CMS Updates FAQs on Section 111 MSP Prescription Drug Coverage Reporting
• HHS Extends Comment Period for Transparency in Coverage Proposed Rules
• FDA Releases Proposed Rule on the Importation of Certain Drugs from Canada
• IRS Updates Questions and Answers on the Individual Shared Responsibility Provision
• Question of the Month